Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach
Lucia Ruxandra Tefas,1 Bianca Sylvester,1 Ioan Tomuta,1 Alina Sesarman,2,3 Emilia Licarete,2,3 Manuela Banciu,2,3 Alina Porfire1 1Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, University of Medicine and Pharmacy “Iuliu Hatieganu”, 2Department...
Main Authors: | Tefas LR, Sylvester B, Tomuta I, Sesarman A, Licarete E, Banciu M, Porfire A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-05-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/development-of-antiproliferative-long-circulating-liposomes-co-encapsu-peer-reviewed-article-DDDT |
Similar Items
-
A Screening Study for the Development of Simvastatin-Doxorubicin Liposomes, a Co-Formulation with Future Perspectives in Colon Cancer Therapy
by: Cristina Ioana Barbălată, et al.
Published: (2021-09-01) -
Tuftsin-Bearing Liposomes Co-Encapsulated with Doxorubicin and Curcumin Efficiently Inhibit EAC Tumor Growth in Mice
by: Murugesan K, et al.
Published: (2020-12-01) -
Active Tumor-Targeting Nano-formulations Containing Simvastatin and Doxorubicin Inhibit Melanoma Growth and Angiogenesis
by: Giorgiana Negrea, et al.
Published: (2022-04-01) -
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
by: Singh S
Published: (2018-03-01) -
Preparation and characterization of curcumin long-circulating liposomes
by: Jing REN, et al.
Published: (2018-12-01)